Analysis of TCGA data showed high induction of Clk1 in gliomas or renal tumors, whereas in bladder urothelial carcinomas and invasive breast cancers, Clk1 expression was decreased (56). The gene discussed is CLK1; the disease is bladder transitional cell carcinoma.